. 2009 Aug 14;85(2):296–301. doi: 10.1016/j.ajhg.2009.07.011

Table 1.

IDS Activity in the Plasma

	IDS Activity (nmol/4 h/mg)
	T1	T6	T12	T18
WT	320 ± 27	243 ± 32.1	220 ± 36.2	198 ± 18.9
Ids^y/−	27 ± 1.5	24 ± 0.6	18 ± 1.1
Ids^y/−+IDS	2400
Ids^y/−+IDS	2700
Ids^y/−+IDS	1995
Ids^y/−+IDS	2090
Ids^y/−+IDS	2405
Ids^y/−+IDS	2820
Ids^y/−+IDS	1900
Ids^y/−+IDS	2340
Ids^y/−+IDS	2300	1410	909	820
Ids^y/−+IDS	1900	950	659	420
Ids^y/−+IDS	2435	1680	1409	1219
Ids^y/−+IDS	2230	1735	1380	1022

IDS activity in the plasma measured at different times after therapy (T1, T6, T12, and T18: 1, 6, 12, and 18 months after the injection, respectively) of WT (n = 3), Ids^y/− (n = 3), and AAV2/5CMV-hIDS-injected Ids^y/− mice.